203 related articles for article (PubMed ID: 20473931)
21. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
22. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.
Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
Int J Cancer; 2003 Jul; 105(6):851-5. PubMed ID: 12767073
[TBL] [Abstract][Full Text] [Related]
24. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
25. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
Jiang W; Cai R; Chen QQ
Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
27. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
28. Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma.
Chen F; Mo Y; Ding H; Xiao X; Wang SY; Huang G; Zhang Z; Wang SZ
Head Neck; 2011 Jan; 33(1):54-9. PubMed ID: 20848417
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.
Fang W; Li X; Jiang Q; Liu Z; Yang H; Wang S; Xie S; Liu Q; Liu T; Huang J; Xie W; Li Z; Zhao Y; Wang E; Marincola FM; Yao K
J Transl Med; 2008 Jun; 6():32. PubMed ID: 18570662
[TBL] [Abstract][Full Text] [Related]
30. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma.
Xiao X; Zhao W; Tian F; Zhou X; Zhang J; Huang T; Hou B; Du C; Wang S; Mo Y; Yu N; Zhou S; You J; Zhang Z; Huang G; Zeng X
Tumour Biol; 2014 Apr; 35(4):3755-63. PubMed ID: 24338690
[TBL] [Abstract][Full Text] [Related]
32. Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma.
Xu Y; Zhao W; Mo Y; Ma N; Midorikawa K; Kobayashi H; Hiraku Y; Oikawa S; Zhang Z; Huang G; Takeuchi K; Murata M
Cancer Sci; 2020 Jul; 111(7):2536-2545. PubMed ID: 32324312
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
34. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
[TBL] [Abstract][Full Text] [Related]
35. Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
Chen T; Long B; Ren G; Xiang T; Li L; Wang Z; He Y; Zeng Q; Hong S; Hu G
J Cell Biochem; 2015 Aug; 116(8):1766-75. PubMed ID: 25736877
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
37. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.
He D; Zeng Q; Ren G; Xiang T; Qian Y; Hu Q; Zhu J; Hong S; Hu G
Eur J Cancer Prev; 2012 Nov; 21(6):569-75. PubMed ID: 22273848
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
39. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
[TBL] [Abstract][Full Text] [Related]
40. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
Li J; Gong P; Lyu X; Yao K; Li X; Peng H
Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
